Peter J Hosein

9PUBLICATIONS
66CO-AUTHORS
Molecular targetsCellular nervous systemPredictive and prognostic markersCancer geneticsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 15, 2026
Olaparib in Patients With Solid Tumors With ATM Alterations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.

Daniel R Carrizosa, Michael Rothe, Pam K Mangat

|Oct 29, 2025
Dethroning of Neuroendocrine Tumor as an Orphan Disease: US Incidence, Prevalence, and Survival in the 21st Century.

Qian Yu, Fan Cao, Peter Hosein

|Dec 03, 2024
Phase II Trial of the PARP Inhibitor, Niraparib, in BAP1 and Other DNA Damage Response Pathway-Deficient Neoplasms.

Thomas J George, Ji-Hyun Lee, David L DeRemer

|May 09, 2024
Genomic Profiling of Rare Undifferentiated Sarcomatoid Subtypes of Pancreatic Carcinomas: In Search of Therapeutic Targets.

Erik B Faber, Harris B Krause, Khalid Amin

|Nov 09, 2023
Multiomic Characterization Reveals a Distinct Molecular Landscape in Young-Onset Pancreatic Cancer.

Ifeanyichukwu Ogobuiro, Yasmine Baca, Jennifer R Ribeiro

|Jun 02, 2023
Comparative Genomic Analysis of Pancreatic Acinar Cell Carcinoma (PACC) and Pancreatic Ductal Adenocarcinoma (PDAC) Unveils New Actionable Genomic Aberrations in PACC.

Vaia Florou, Andrew Elliott, Matthew H Bailey

Pageof 2

Frequent Collaborators

2 joint publications

Ignacio Garrido-Laguna

2 joint publications

Matthew Oberley

2 joint publications

Jashodeep Datta

2 joint publications

Vaia Florou